NURLU TEMEL, E. Et Al. 2023. The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. Journal of Clinical Medicine , vol.12, no.5 .

NURLU TEMEL, E., SAVRAN, M., ERZURUMLU, Y., Hasseyid, N., BÜYÜKBAYRAM, H. İ., Okuyucu, G., ... SEVÜK, M. A.(2023). The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. Journal of Clinical Medicine , vol.12, no.5.

NURLU TEMEL, Esra Et Al. "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury," Journal of Clinical Medicine , vol.12, no.5, 2023

NURLU TEMEL, Esra N. Et Al. "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury." Journal of Clinical Medicine , vol.12, no.5, 2023

NURLU TEMEL, E. Et Al. (2023) . "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury." Journal of Clinical Medicine , vol.12, no.5.

@article{article, author={Esra NURLU TEMEL Et Al. }, title={The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury}, journal={Journal of Clinical Medicine}, year=2023}